Track iCoreConnect Inc. — Monitor price, dividends, and performance in your free portfolio

Start Tracking Free

iCoreConnect Inc. ICCT · Stock Open iCoreConnect Inc. in new tab

0.001100 USD
EPS
-45.78
P/B
-0.02
Beta
33.47
Loading chart...
Key Metrics
Earnings dateJune 15, 2026
EPS-45.78
Book Value-0.05
Price to Book-0.02
Debt/Equity2645.65
% Insiders9.551%
Growth
Revenue Growth-0.12%

DCF Valuation

Tweak assumptions to recompute fair value for iCoreConnect Inc. (ICCT)
Currency: USD
DCF Assumptions
Decimal (e.g., 0.10 = 10%). Range allows declines (−50%) to strong growth (+50%).
Decimal (e.g., 0.30 = 30%).
Decimal (e.g., 0.04 = 4%).
Decimal (e.g., 0.20 = 20%).
Percent number (e.g., 3 = 3%).
Percent number (e.g., 10 = 10%).
Percent number (e.g., 5 = 5%).
DCF Result

Fair Value (DCF)
Current Price
Upside
WACC
Terminal PV
Σ PV of FCFs
Note: historical bars show reported FCF (for context); forward bars show PV of projected FCF; if no per-year data, totals are shown.

iCoreConnect Inc. Logo iCoreConnect Inc. Analysis (ICCT)

United States Health Care Official Website Stock

Is iCoreConnect Inc. a good investment? iCoreConnect Inc. (ICCT) is currently trading at 0.001100 USD.

Earnings Schedule: iCoreConnect Inc. is expected to release its next earnings report on June 15, 2026.

Investor FAQ

Does iCoreConnect Inc. pay a dividend?

No, it does not currently pay a dividend.

What asset class is iCoreConnect Inc.?

iCoreConnect Inc. is classified as a Stock. You can compare it against its peer in the "Related Symbols" list.

When is the next earnings date?

The next earnings date is projected to be June 15, 2026. The company currently has a trailing EPS of -45.78.

Company Profile

iCoreConnect Inc. develops and markets health insurance portability and accountability act (HIPAA) compliant cloud-based software as a service (SaaS) in the United States. The company offers iCoreRx, a HIPAA compliant electronic prescription software; iCorePDMP, an add-on for iCoreRx that integrates with state databases to automate prescription drug monitoring; iCoreVerify and iCoreVerify+, a HIPAA compliant SaaS solution that automatically retrieves a patient insurance eligibility breakdown to verify their benefits; iCoreClaims for processing and managing claims submitted by policyholders or dental care provider; and iCoreHuddle and iCoreHuddle+, which reveals the revenue potential of each patient. It also provides iCoreCodeGenius, a medical coding reference SaaS solution; iCoreExchange, a HIPAA compliant SaaS email solution using direct protocol that allows doctors to send and receive secure email with attachments to and from other healthcare professionals in the network; iCoreCloud provides the ability to backup on-premise servers and computers to the cloud; iCorePay, a cloud-based financial technology solution designed to streamline the billing and payment processes for healthcare providers; iCoreSecure, a secure SaaS solution that solves privacy concerns; and iCoreIT. In addition, the company offers iCoreVerify provides automated insurance verifications; iCoreVerify+ that combines automation with concierge assistance for verification; and iCoreVerifyPro, it manages all verifications, entering insurance benefits directly into patient charts, ensuring insurance information. The company was formerly known as iMedicor, Inc. and changed its name to iCoreConnect Inc. in June 2017. The company was founded in 1992 and is headquartered in Ocoee, Florida. On June 2, 2025, iCoreConnect Inc., along with its affiliate, filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the Middle District of Florida.

Exchange Ticker
PNK (United States) ICCT
Trades
Dividend History paid per year (USD)
No dividend history available.
Stock Splits
Split Date Split Ratio to 1
Dec. 23, 2024 0.050000
Explore Premium Features

Unlock detailed news and exclusive insights with our Premium subscription.

See Pricing Plans

Fundamentals

Under Construction

This feature will be available soon. Stay tuned!

Follow us on Twitter for updates: @allinvestview

Check out our Roadmap for upcoming features.

Community Discussion